Jasco Pharmaceuticals, LLC announced that preclinical data on its PIM inhibitor program would be presented at the 2013 ASH Annual Meeting and Exposition to be held on December 7-10 in New Orleans, LA.
The poster, entitled “Overcoming CD28-Mediated Multi-Drug Resistance With a Novel PIM2 Inhibitor,” will be presented on Saturday, December 7, 2013 from 5:30 PM - 7:30 PM at Exhibit Hall G, Ernest N. Morial Convention Center, abstract 1931.
Help employers find you! Check out all the jobs and post your resume.
